Recent

% | $
Quotes you view appear here for quick access.

BIOLASE, Inc. Message Board

  • Nate_Sarah Nate_Sarah Feb 29, 2000 9:18 AM Flag

    News....

    This was posted as news in the last minute or so on Yahoo:
    http://biz.yahoo.com/prnews/000229/ca_biolase_1.html

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Tuesday February 29, 8:59 am Eastern
      Time

      Company Press Release

      SOURCE: Biolase Technology,
      Inc.

      Biolase Diode Laser Featured in Live Surgery Broadcast
      At
      Chicago Dental Society Midwinter Meeting

      SAN
      CLEMENTE, Calif., Feb. 29 /PRNewswire/ -- Biolase
      Technology, Inc. (Nasdaq: BLTI - news), today announced that
      its TwiLite(TM)
      diode laser was demonstrated
      during a live closed-circuit TV broadcast from
      Northwestern University Dental School to an auditorium
      of
      dentists at the Chicago Dental Society's 135th Midwinter
      Meeting last week. The demonstration, an aesthetic tissue
      recontouring
      surgery, was performed by Peter Rinaldi, D.M.D., a
      renowned cosmetic dentist.

      Dr. Rinaldi's
      presentation, ``Veneers: A Demonstration in Preparation, Design
      and Cementation,'' focused on the necessary
      fundamentals
      for properly preparing and seating cosmetic veneers.
      Following the surgery, Dr. Rinaldi commented, ``The TwiLite
      worked very well and
      the results were fantastic. I
      was able to recontour the tissue without any
      bleeding. The advantages of using diode lasers are that
      the
      margins are very predictable, there is almost no
      post-operative discomfort and the tissue heals very well
      compared to other
      technologies. The diode laser is a
      must for any dentist performing cosmetic
      procedures.''

      Dr. Rinaldi is a renowned cosmetic dentist in private
      practice with Dr. Larry Rosenthal in New York City. He is
      the clinical director
      for some of the leading
      aesthetic hands-on post graduate courses, Aesthetic
      Advantage, which are presented at Baylor College
      of
      Dentistry, New York University, Palm Beach Community College
      and the University of Kentucky College of Dentistry.
      Dr. Rinaldi has also
      published numerous articles
      on cosmetic dentistry and lectures
      extensively.

      The TwiLite diode laser, which received clearance
      from the Food and Drug Administration in late
      September 1999, is a revolutionary
      lightweight laser
      ideally suited for a range of soft tissue procedures. It
      is equipped with robust, state-of-the-art features
      favored
      by dentists, including a ``power on demand'' foot
      switch that allows users to quickly increase or decrease
      power levels while
      continuing
      treatment.

      Dental diode laser sales in the U.S. are projected to
      increase 300 percent in 2000 over 1999, and an additional
      55 percent in 2001,
      according to a recent
      independent study. The study, ``U.S. Market for Dental
      Products 2000,'' prepared by the Millennium Research
      Group
      in Toronto, Canada, also projects that dental diode
      laser sales will continue to increase more than 20
      percent per year through 2004.

      Jeffrey W. Jones,
      Biolase president and CEO, commented, ``Cosmetic
      procedures represent a rapidly growing business for
      dentists, and
      one of the most requested procedures is
      veneers for the anterior teeth. According to the leading
      cosmetic dentists, a diode laser is
      clearly the most
      effective, and a necessary, tool for tissue recontouring and
      'smile design.'''

      • 2 Replies to Nate_Sarah
      • diode soft tissue laser FDA aproved today

      • Jones added, ``In just a short time, Biolase has
        become the diode laser of choice among prominent and
        influential dentists, and that
        was the reason our laser
        was selected for this important demonstration.
        Attendance at courses for cosmetic dentistry such as these
        is
        growing, fueled by dentists' desire to provide their
        patients with additional services, increase revenue and
        improve the profitability
        of their practices. Biolase
        has already been selected by several of the top
        courses and is pursuing opportunities with all of the
        other
        most prominent courses and their key dentists. Having
        our laser featured at these courses and used by their
        dentists are two of the
        most effective ways to market
        and sell our feature-rich TwiLite.''

        Biolase
        Technology, Inc. (www.biolase.com), manufactures and markets
        advanced dental, cosmetic, aesthetic and surgical
        products,
        including Hydrokinetic(TM) surgical cutting systems and
        other advanced laser and non-laser based products for
        the professional and home
        consumer market. The
        company's products incorporate patented and patent-pending
        technologies in the pursuit of painless surgery.

        The
        matters discussed in this news release include
        forward-looking statements which are subject to various risks,
        uncertainties and
        other factors that could cause actual
        results to differ materially from the results anticipated
        in such forward-looking statements.
        Such risks,
        uncertainties and other factors include, but are not limited
        to, the effect of actions of third parties,
        including
        governmental officials, the timely development and acceptance
        of new products, the impact of competitive products
        and pricing, and
        other risks detailed from time to
        time in the Company's filings with the Securities and
        Exchange Commission, including the reports on
        Forms
        10-K and 10-Q. These forward-looking statements
        represent the Company's judgment as of the date of this
        release. The Company
        disclaims, however, any intent or
        obligation to update these forward-looking statements.

 
BIOL
1.87-0.06(-3.11%)Sep 26 4:00 PMEDT